Journal Article
Perlman J, Kjaer K.  2016.  Neonatal and Maternal Temperature Regulation During and After Delivery.. Anesth Analg. 123(1):168-72.
Lien CA.  2010.  Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent? Anesthesiology. 112(1):16-8.
Pamnani A, Rosenstein M, Darwich A, Wolfson A.  2010.  Neuraxial anesthesia for labor and cesarean delivery in a parturient with hereditary antithrombin deficiency on recombinant human antithrombin infusion therapy.. J Clin Anesth. 22(6):450-3.
Oberg JA, Dave AN, Bruce JN, Sands SA.  2014.  Neurocognitive functioning and quality of life in patients with recurrent malignant gliomas treated on a phase Ib trial evaluating topotecan by convection-enhanced delivery.. Neurooncol Pract. 1(3):94-100.
Hung JC, Azam N, Puttanniah V, Malhotra V, Gulati A.  2014.  Neurolytic transversus abdominal plane block with alcohol for long-term malignancy related pain control.. Pain Physician. 17(6):E755-60.
So M, Bansal N, Piracha MM.  2018.  Neuromodulation and Pancreatic Cancer Pain.. J Palliat Med. 21(8):1064-1066.
Jotwani R, Mehta N, Baig E, Gupta A, Gulati A.  2020.  Neuromodulation and the Epidemiology of Magnetic Resonance Utilization for Lung, Breast, Colon, and Prostate Cancer.. Neuromodulation.
Grosland JO, Todd MM, Goldstein PA.  2018.  Neuromonitoring in the ambulatory anesthesia setting: a pro-con discussion.. Curr Opin Anaesthesiol.
Goudsouzian NG, Alifimoff JK, Liu LM, Foster V, McNulty B, Savarese JJ.  1989.  Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane.. Br J Anaesth. 62(3):263-8.
Goudsouzian NG, Alifimoff JK, Eberly C, Smeets R, Griswold J, Miler V, McNulty BF, Savarese JJ.  1989.  Neuromuscular and cardiovascular effects of mivacurium in children.. Anesthesiology. 70(2):237-42.
Boros EE, Samano V, Ray JA, Thompson JB, Jung DK, Kaldor I, Koble CS, Martin MT, Styles VL, Mook RA et al..  2003.  Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys.. J Med Chem. 46(12):2502-15.
Ginsburg S, Kitz RJ, Savarese JJ.  1971.  Neuromuscular blocking activity of a new series of quaternary N-substituted choline esters.. Br J Pharmacol. 43(1):107-26.
Kopman AF, Lien CA, Naguib M.  2011.  Neuromuscular dose-response studies: determining sample size.. Br J Anaesth. 106(2):194-8.
Goudsouzian NG, Ryan JF, Savarese JJ.  1974.  The neuromuscular effects of pancuronium in infants and children.. Anesthesiology. 41(1):95-8.
Okamoto M, Walewski JL, Artusio JF, Riker WF.  1992.  Neuromuscular pharmacology in rat neonates: development of responsiveness to prototypic blocking and reversal drugs.. Anesth Analg. 75(3):361-71.
Hemmings HC.  2004.  Neuroprotection by Na+ channel blockade.. J Neurosurg Anesthesiol. 16(1):100-1.
Grobelny BT, Rubin D, Fleischut P, Rubens E, Mack PFogarty, Fink M, Placantonakis DG, Elowitz EH.  2012.  Neurosurgical management of symptomatic thoracic spinal ossification in a patient with fibrodysplasia ossificans progressiva.. J Neurosurg Spine. 16(3):285-8.
Perouansky M, Hemmings HC.  2009.  Neurotoxicity of general anesthetics: cause for concern? Anesthesiology. 111(6):1365-71.
Walsh KJ, Tan KSee, Zhang H, Amar D.  2017.  Neutrophil-lymphocyte ratio and risk of atrial fibrillation after thoracic surgery.. Interact Cardiovasc Thorac Surg. 24(4):555-559.
Ferraris A, Szmulewicz AG, Burry L, Phipps A, Wunsch H, Scales DC, Angriman F.  2023.  New antipsychotic prescription and recurrent infections among adult sepsis survivors: A population-based cohort study.. Pharmacoepidemiol Drug Saf.
Donlon JV, Ali HH, Savarese JJ.  1974.  A new approach to the study of four nondepolarizing relaxants in man.. Anesth Analg. 53(6):934-9.
Ariel P, Ryan TA.  2012.  New insights into molecular players involved in neurotransmitter release.. Physiology (Bethesda). 27(1):15-24.
Savarese JJ.  1981.  The new neuromuscular blocking drugs are here.. Anesthesiology. 55(1):1-3.
Eger EI, Raines DE, Shafer SL, Hemmings HC, Sonner JM.  2008.  Is a new paradigm needed to explain how inhaled anesthetics produce immobility? Anesth Analg. 107(3):832-48.
Neumann S, Eliseeva E, McCoy JG, Napolitano G, Giuliani C, Monaco F, Huang W, Gershengorn MC.  2011.  A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor.. J Clin Endocrinol Metab. 96(2):548-54.